Omnicell (OMCL) Share-based Compensation (2010 - 2026)
Omnicell's (OMCL) quarterly Share-based Compensation came in at $12.2 million in Q2 2026, up 15.93% year-over-year from $10.5 million in Q2 2025, and up 28.52% quarter-over-quarter from $9.5 million in Q1 2026.
Analysis
Omnicell (OMCL) Share-based Compensation (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Share-based Compensation for 17 consecutive years, with $12.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 15.93% year-over-year to $12.2 million in Q2 2026; TTM through Jun 2026 was $44.9 million, a 6.99% increase from a year earlier, with the FY2025 full-year figure at $44.5 million, up 13.19% from the prior year.
- Share-based Compensation was $12.2 million for Q2 2026 at Omnicell, up from $9.5 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $17.5 million in Q4 2022 and troughed at $8.6 million in Q1 2024.
- A 5-year average of $12.7 million and a median of $12.1 million in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation soared 37.68% in 2022 and plunged 38.46% in 2024, its largest moves.
- Over 5 years, Share-based Compensation stood at $17.5 million in 2022, then slumped by 30.42% to $12.2 million in 2023, then dropped by 25.83% to $9.0 million in 2024, then surged by 32.49% to $12.0 million in 2025, then climbed by 1.93% to $12.2 million in 2026.
- The last three Share-based Compensation figures came in at $12.2 million (Q2 2026), $9.5 million (Q1 2026), and $12.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 27.46 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 12.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.21 Mn |
| Mar 31, 2026 | 9.50 Mn |
| Dec 31, 2025 | 11.98 Mn |
| Sep 30, 2025 | 11.21 Mn |
| Jun 30, 2025 | 10.53 Mn |
| Mar 31, 2025 | 10.79 Mn |
| Dec 31, 2024 | 9.04 Mn |
| Sep 30, 2024 | 11.61 Mn |
| Jun 30, 2024 | 10.03 Mn |
| Mar 31, 2024 | 8.64 Mn |
| Dec 31, 2023 | 12.19 Mn |
| Sep 30, 2023 | 14.98 Mn |
| Jun 30, 2023 | 14.09 Mn |
| Mar 31, 2023 | 14.04 Mn |
| Dec 31, 2022 | 17.52 Mn |
| Sep 30, 2022 | 17.31 Mn |
| Jun 30, 2022 | 17.21 Mn |
| Mar 31, 2022 | 16.21 Mn |
| Dec 31, 2021 | 14.68 Mn |
| Sep 30, 2021 | 13.67 Mn |